Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr329.90 DKK
Change Today -8.30 / -2.45%
Volume 893.3K
NZYMB On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Copenhagen
Frankfurt
As of 11:04 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steen Riisgaard

Former Chief Executive Officer and President, Novozymes A/S
AgeTotal Calculated CompensationThis person is connected to 58 board members in 9 different organizations across 10 different industries.

See Board Relationships
63--

Background*

Mr. Steen Riisgaard served as the Chief Executive Officer and President at Novozymes A/S of Sustainable Performance Group AG from 2000 to April 01, 2013. Mr. Riisgaard served as Chief Executive Officer of Novo Nordisk A/S from 1989 to 2000. He served as Director of Detergent Enzyme Division at Novo Industri A/S since 1986 and Enzyme Process Research at Novo Industri A/S since 1985. He served as Corporate Executive Vice President, Enzyme Business, Novo Nordisk A/S, from ...

Read Full Background

Corporate Headquarters*

Krogshoejvej 36
Bagsvaerd, -- 2880

Denmark

Phone: 45 44 46 00 00
Fax: 45 44 46 99 99

Board Members Memberships*

Director
Chairman
Chairman
Director
Chairman of The Board
Deputy Chairman
2002-Present
Chairman
2008-N/A
Former Director and Member of Remuneration Committee
2011-Present
Chairman, Chairman of Remuneration Committee and Chairman of Nomination Committee

Education*

MS 1976
Københavns Universitet

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr329.90 DKK -8.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.5M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.